Thrombolytic therapy in prosthetic valve thrombosis in the second trimester of pregnancy
DOI:
https://doi.org/10.18203/2349-3933.ijam20201625Keywords:
Pregnancy, Prosthetic valve, Thrombolysis, ThrombosisAbstract
Pregnancy with mechanical valves requires anticoagulation, the risk of bleeding and embryopathy associated with oral anticoagulation must be weighed against the risk of valve thrombosis. In the presence of a mechanical valve thrombosis, an appropriate treatment modality must be selected. Prosthetic valve thrombosis during pregnancy requires immediate therapy such as valve replacement, thrombolytic therapy, or surgical thrombectomy. A course of thrombolytic therapy may be considered as a first-line therapy for prosthetic heart valve thrombosis. We describe a primigravida (second trimester) with mitral valve replacement status presenting with acute prosthetic valve thrombosis and treated successfully with intravenous streptokinase.
References
Sani MU, Karaye KM, Borodo MM. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Africa. 2007 Jul;18(5):295-9.
Edmunds LH. Thromboembolic complications of current cardiac valvular prosthesis. Ann Thorac Surg. 1982;34:96-106.
Kontos Jr GJ, Schaff HV, Orszulak TA, Puga FJ, Pluth JR, Danielson GK. Thrombotic obstruction of disc valves: clinical recognition and surgical management. Ann Thorac Surg. 1989;48(1):60-5.
Thorburn CW, Morgan JJ, Shanahan MX, Chang VP. Long-term results of tricuspid valve replacement and the problem of pros- thetic valve thrombosis. Am J Cardiol. 1983;51:1128-32.
Gartman EJ. The use of thrombolytic therapy in pregnancy. Obstetr Med. 2013 Sep;6(3):105-11.
Lengyel M, Laszlo V. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis. 2001;10:636-49.
Silber H, Khan SS, Matloff JM, Chaux A, DeRobertis M, Gray R. The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation. 1993;87:30-7.